These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3382304)

  • 1. Physician knowledge, attitudes, and behavior related to reporting adverse drug events.
    Rogers AS; Israel E; Smith CR; Levine D; McBean AM; Valente C; Faich G
    Arch Intern Med; 1988 Jul; 148(7):1596-600. PubMed ID: 3382304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug event reporting. Improving the low US reporting rates.
    Edlavitch SA
    Arch Intern Med; 1988 Jul; 148(7):1499-503. PubMed ID: 3382293
    [No Abstract]   [Full Text] [Related]  

  • 3. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse-drug-reaction monitoring.
    Faich GA
    N Engl J Med; 1986 Jun; 314(24):1589-92. PubMed ID: 3713757
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National adverse drug reaction surveillance. 1986.
    Faich GA; Dreis M; Tomita D
    Arch Intern Med; 1988 Apr; 148(4):785-7. PubMed ID: 3355297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reaction reporting.
    Bosco LA
    Am J Gastroenterol; 1987 Apr; 82(4):356-7. PubMed ID: 3565343
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse drug reaction reporting system: developing a well-monitored program.
    Kilarski DJ; Ziegler B; Coarse J; Buchanan C
    Hosp Formul; 1986 Sep; 21(9):949-52. PubMed ID: 10289704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for self-reported adverse drug events among Medicare enrollees.
    Oladimeji O; Farris KB; Urmie JG; Doucette WR
    Ann Pharmacother; 2008 Jan; 42(1):53-61. PubMed ID: 18029427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
    Aziz Z; Siang TC; Badarudin NS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacist and adverse drug reaction reporting.
    Pearson K
    Hosp Pharm; 1982 Aug; 17(8):421-2, 427-30. PubMed ID: 10256700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food and Drug Administration's adverse drug reaction monitoring program.
    Lee B; Turner WM
    Am J Hosp Pharm; 1978 Aug; 35(8):929-32. PubMed ID: 677138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmarketing surveillance.
    Oleen MA
    Can J Hosp Pharm; 1987 Oct; 40(5):171-2, 179-80. PubMed ID: 10284449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System.
    Wysowski DK; Barash D
    Arch Intern Med; 1991 Oct; 151(10):2003-8. PubMed ID: 1929688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National adverse drug reaction reporting. 1984-1989.
    Faich GA
    Arch Intern Med; 1991 Aug; 151(8):1645-7. PubMed ID: 1872669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reporting of side-effects--a system in need of improvement. Reporting of a physician questionnaire].
    Ekbom Y; Hedenmalm K; Dalin L; Lönnroth K; Persson I
    Lakartidningen; 2002 Aug; 99(34):3290-5. PubMed ID: 12362847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal reporting of adverse medical events to the FDA Adverse Events Reporting System by nurse practitioners and physician assistants.
    Ehrenpreis ED; Sifuentes H; Ehrenpreis JE; Smith ZL; Marshall ML
    Expert Opin Drug Saf; 2012 Mar; 11(2):177-83. PubMed ID: 22316142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project--six sites, United States, January 1-June 15, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Apr; 54(15):380-3. PubMed ID: 15843786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.